 |
|
Maximum: 9 CME cr.
0 new discussion posts (35 published)
Sign in to view your progression
|
The 4th edition of the Masterclass presents an up-to-date, standardised knowledge of the multidisciplinary management of gynaecological cancers to future gynaecological oncologists across Europe. The course furthers the organisations’ key goal of harmonising gynaecological oncology training and education throughout Europe.
The primary learning objective of the Masterclass is to cover the entire curriculum of the gynae-oncological subspecialty as defined by ESGO, which defines the European standards of training and care in Gynaecological Oncology.
This full-immersion, clinically oriented, multidisciplinary event offers plenary lectures, regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines.
Key Topics:
- Vulvar cancer
- Cervical Cancer
- Malignant tumors of the uterus
- Malignant tumors of the ovaries
- Pelvic Anatomy
- Familiar Gynaecological Cancers
The Masterclass has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 9 European CME credits (ECMEC®s).
Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME® is an institution of the European Union of Medical Specialists (UEMS), www.uems.eu.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™.
Information on the process to convert EACCME® credits to AMA credits can be found at www.ama-assn.org/education/earn-credit-participation-international-activities. Live educational activities occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC® credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Date of expiry: 2023-12-10
|
ACCREDITED ACTIVITY
Module 1: Vulvar cancer
|
|
|
ACCREDITED ACTIVITY
Module 1: Vulvar cancer | Assessment
|
|
|
ACCREDITED ACTIVITY
Module 2: Cervical cancer
|
|
|
ACCREDITED ACTIVITY
Module 2: Cervical cancer | Assessment
|
|
|
ACCREDITED ACTIVITY
Module 3: Malignant tumours of the uterus
|
|
|
ACCREDITED ACTIVITY
Module 3: Malignant tumours of the uterus | Assessment
|
|
|
ACCREDITED ACTIVITY
Module 4: Malignant tumours of the ovaries
|
|
|
ACCREDITED ACTIVITY
Module 4: Malignant tumours of the ovaries | Assessment
|
|
|
ACCREDITED ACTIVITY
Module 5: Miscellaneous
|
|
|
ACCREDITED ACTIVITY
Module 5: Miscellaneous | Assessment
|
|
|
CERTIFICATE
Evaluation and Certificate
|
|
